Hey jobo. If you go to research/valuation thread and look at @ma420 post, Wilson's does a brief comparison to pluvicto, and specifically assess cohort 2 and 3 without cohort 1, which was most likely underdosing.
- Forums
- ASX - By Stock
- Ann: Theranostic prostate cancer trial advances to multi-dose
Hey jobo. If you go to research/valuation thread and look at...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.59 |
Change
0.100(1.34%) |
Mkt cap ! $2.393B |
Open | High | Low | Value | Volume |
$7.50 | $7.62 | $7.45 | $5.193M | 687.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 57 | $7.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.60 | 5738 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 606 | 7.590 |
14 | 2543 | 7.580 |
10 | 1994 | 7.570 |
4 | 11095 | 7.560 |
2 | 512 | 7.550 |
Price($) | Vol. | No. |
---|---|---|
7.600 | 1478 | 11 |
7.610 | 22531 | 19 |
7.620 | 24812 | 14 |
7.630 | 22483 | 2 |
7.640 | 20937 | 4 |
Last trade - 15.06pm 13/09/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online